Marker Therapeutics

Marker Therapeutics: Focused on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. MT-401, its lead MultiTAA-specific T cell product candidate, has received Orphan Drug Designation for the treatment of post-transplant acute myeloid leukemia (AML) and is currently in a Phase 2 study (n=160) evaluating clinical efficacy in both the adjuvant (n=120) and active disease (n=40) setting. Topline results from the active disease group is expected in Q1 2022.
Based in...
US - West South Central
Clinical Stage
Phase l or ll
Disease Space
Biotechnology, Pharmaceuticals
Investement Strategy
Under the Radar
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Cell Therapy
3200 Southwest Fwy #2240, Phoenix Tower
Houston, TX 77027
United States

Company Participants at Solebury Trout Hamptons CEO Roundtable 2021

  • Peter L. Hoang, President & CEO

Top 10 Holders of Marker Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
NEA Management Co. 12.91 10,714,285 20.25 13F 6/30/21
Eastern Capital Ltd. 7.39 3,550,001 6.71 Stakes 3/15/21
Aisling Capital Management LP 3.79 3,142,857 5.94 13F 6/30/21
The Vanguard Group, Inc. 3.24 2,691,710 5.09 Funds 7/31/21
Vanguard Group, Inc. (Subfiler) 3.20 2,654,043 5.02 13F 6/30/21
Millennium Management LLC 1.64 1,364,632 2.58 13F 6/30/21
Two Sigma Advisers LP 1.63 1,354,600 2.56 13F 6/30/21
Two Sigma Investments LP 1.21 1,000,328 1.89 13F 6/30/21
Victory Capital Management, Inc. (Investment Management) 1.11 923,683 1.75 13F 6/30/21
D.E. Shaw & Co., Inc. 0.76 631,193 1.19 13F 6/30/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.